Bronchoscopic Closure of Bronchopleural Fistulas With Occlutech Figulla ASD N Occluder Device

NCT01153074 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2017-05-25

No results posted yet for this study

Summary

The purpose of this study is to evaluate the feasibility of closing bronchopleural fistulas with devices originally developed for correction of cardiac septal defects deployed through bronchoscopic procedures.

Conditions

  • Bronchopleural Fistula

Interventions

DEVICE

Closure of bronchopleural fistula with Occlutech Figulla

Patients with bronchopleural fistulas will be submitted to a bronchoscopic procedure to deploy the cardiac septal defect occluder in the fistula traject.

Sponsors & Collaborators

  • InCor Heart Institute

    collaborator OTHER
  • Occlutech International AB

    collaborator INDUSTRY
  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Miguel L. Tedde, MD, PhD · Heart Institute (InCor) HC of the Sao Paulo University School

Study Design

Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2015-12-31
Completion
2016-10-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01153074 on ClinicalTrials.gov